Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0034 | 0.129 | 0.5721 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0212 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0566 | 0.0566 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0212 | 0.043 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.129 | 0.129 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0034 | 0.129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.2385 | 0.2385 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0125 | 0.0125 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0047 | 0.2161 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0212 | 0.0212 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.5555 | 0.5555 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0154 | 0.9689 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.1281 | 0.1281 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.2385 | 0.2385 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0125 | 0.0125 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.5555 | 0.5555 |
Leishmania major | pyruvate kinase | 0.0034 | 0.129 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.129 | 0.5529 |
Echinococcus granulosus | pyruvate kinase | 0.0034 | 0.129 | 0.1331 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0047 | 0.2161 | 0.2231 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0043 | 0.1889 | 1 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0024 | 0.0566 | 0.0566 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.3684 | 0.3684 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0212 | 0.0496 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.129 | 0.5529 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0212 | 0.0496 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Leishmania major | pyruvate kinase | 0.0034 | 0.129 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0047 | 0.2161 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0018 | 0.0125 | 0.0125 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0212 | 0.0212 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0158 | 1 | 1 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0043 | 0.1889 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0034 | 0.129 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3684 | 0.3684 |
Brugia malayi | RNA binding protein | 0.0068 | 0.3684 | 0.3684 |
Echinococcus multilocularis | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.3684 | 0.3684 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.2385 | 0.2385 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.5555 | 0.5555 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.3684 | 0.3684 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0095 | 0.5555 | 0.5555 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0024 | 0.0566 | 0.2106 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3684 | 0.3684 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.129 | 0.5 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0158 | 1 | 1 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.129 | 0.5 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0034 | 0.129 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.5555 | 0.5734 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1281 | 0.1281 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.1281 | 0.1281 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0125 | 0.0129 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0212 | 0.5 |
Chlamydia trachomatis | pyruvate kinase | 0.0034 | 0.129 | 0.5 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.129 | 0.129 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0125 | 0.0129 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.3684 | 0.3803 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3684 | 0.3684 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0212 | 0.0212 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0047 | 0.2161 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0125 | 0.0129 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3684 | 0.3684 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.5555 | 0.5734 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0047 | 0.2161 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.5555 | 0.5555 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0047 | 0.2161 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0034 | 0.129 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.3684 | 0.3684 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.3684 | 0.3684 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0212 | 0.0212 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0034 | 0.129 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0212 | 0.0212 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0212 | 0.043 |
Plasmodium falciparum | pyruvate kinase | 0.0034 | 0.129 | 0.6603 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.129 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.2385 | 0.2385 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0034 | 0.129 | 0.129 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0034 | 0.129 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.3684 | 0.3684 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0212 | 0.0219 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3684 | 0.3684 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.5555 | 0.5555 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0125 | 0.0125 |
Giardia lamblia | Pyruvate kinase | 0.0034 | 0.129 | 0.6603 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0034 | 0.129 | 0.129 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0043 | 0.1889 | 1 |
Mycobacterium ulcerans | pyruvate kinase | 0.0034 | 0.129 | 1 |
Plasmodium vivax | pyruvate kinase, putative | 0.0034 | 0.129 | 0.5721 |
Echinococcus multilocularis | pyruvate kinase | 0.0027 | 0.0786 | 0.0786 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0095 | 0.5555 | 0.5555 |
Loa Loa (eye worm) | acetyltransferase | 0.0158 | 1 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0034 | 0.129 | 0.1331 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.